United States· US:24979-160_1dc7a361-08d4-47f5-a74c-6ad4bb35a976
mycophenolic acid
A medicinal product containing mycophenolate sodium, registered in United States by Upsher-Smith Laboratories, LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- MYCOPHENOLATE SODIUM
- Manufacturer
- Upsher-Smith Laboratories, LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc112497916044120 TABLET, DELAYED RELEASE in 1 BOTTLE (24979-160-44)
- ndc1124979-160-44
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mycophenolate sodium in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMYCOPHENOLIC ACID ACCORDACCORD HEALTHCARE POLSKA Sp. z o.o., Varšava
- BelgiumAccempa 180 mgTeva Pharma Belgium
- FinlandMyastadSTADA Arzneimittel AG
- GermanyMycophenolsäure HexalHexal Ag
- IrelandMyfortic 360 mg gastro-resistant tabletsPCO Manufacturing Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Mycophenolsäure Hexal
- Spain · Ceptava
- Italy · Ceptava
- Portugal · Ácido Micofenólico Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fb658e3b-e453-4d3b-a5a3-b44b4f87a23f GET /v1/drugs/fb658e3b-e453-4d3b-a5a3-b44b4f87a23f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "180",
"substance": "MYCOPHENOLATE SODIUM",
"productndc": "24979-160",
"dosage_form": "TABLET, DELAYED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA214289",
"marketing_category": "ANDA"
}See everything about mycophenolate sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.